Catalent | CTLT - Pendapatan Penjualan



Penjualan Perubahan Tanggal
Agilent USD 1.8B 63M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Bruker USD 823.4M 153.8M 2026-03
Centene USD 49.94B 210M 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Cigna USD 68.52B 3.95B 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
Elevance Health USD 49.5B 200M 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Humana USD 39.65B 7.13B 2026-03
Illumina USD 1.09B 70M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
J&J USD 24.1B 500M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Lonza CHF 3.58B 63M 2025-06
McKesson USD 92.3B 13.86B 2026-03
Merck EUR 5.13B 120M 2026-03
Merck USD 16.29B 110M 2026-03
Mettler Toledo International USD 947.13M 182.87M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Quest Diagnostics USD 2.9B 90M 2026-03
Repligen USD 194M 3.91M 2026-03
Revvity USD 711M 61.06M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
UnitedHealth USD 111.7B 1.5B 2026-03
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.27B 338M 2026-03
West Pharmaceutical Services USD 844.9M 39.9M 2026-03